The global healthcare industry continued its hot streak in 2018, with bigger transactions that could reshape the landscape.
In a period of rapid consolidation across the industry, transaction volume is expected to remain high next year, as well. While volume soared in 2018, a number of large transaction marked the year.
Here are the biggest international healthcare deals of 2018, as ranked by Business Insider:
- Takeda’s (Japan) $77 billion acquisition of Shire (United States)
- Cigna’s $67 billion takeover of Express Scripts (United States)
- GlaxoSmithKline’s (UK) $13 billion stake in Novartis (Switzerland)
- Sanofi’s (France) $11 billion purchase of Bioverativ (United States)
- KKR’s $10 billion acquisition of Envision (United States)
- Celgene’s $9 billion acquisition of Juno (United States)
- Novartis’ (Switzerland) $8 billion purchase of AveXis (Unites States)
See the full story below:
Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."